BPW
ABBV icon

Bingham Private Wealth’s AbbVie ABBV Stock Holding History

Bingham Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.39M Buy
6,404
+1,385
+28% +$307K 1.11% 25
2025
Q4 		$1.15M Buy
+5,019
New +$1.14M 0.99% 27
2025
Q2 		$1.08M Sell
5,840
-608
-9% -$113K 1.03% 25
2025
Q1 		$1.35M Sell
6,448
-545
-8% -$106K 1.4% 17
2024
Q4 		$1.24M Buy
+6,993
New +$1.29M 1.32% 17

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bingham Private Wealth's ABBV Position: Q1 2026 in Review

Bingham Private Wealth increased its AbbVie (ABBV) stake by 28% in Q1 2026, buying an estimated $307K and bringing the position to 6,404 shares worth $1.39M. The position accounts for 1.11% of the portfolio, ranked #25.

Bingham Private Wealth first reported a position in ABBV in Q4 2024 and has held it in 5 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Bingham Private Wealth held 6,404 shares of AbbVie worth $1.39M as of Q1 2026.
  • Bingham Private Wealth bought 1,385 AbbVie shares in Q1 2026, an estimated $307K.
  • AbbVie made up 1.11% of Bingham Private Wealth's portfolio in Q1 2026, its #25 holding.
  • Bingham Private Wealth first reported a position in AbbVie in Q4 2024 and has held it in 5 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Bingham Private Wealth's 13F filing for Q1 2026, filed 7 May 2026.